Variable | n (%) |
Gender | |
Male | 95 (76.6) |
Female | 29 (23.4) |
Age (years) | |
<60 | 98 (79.0) |
≥60 | 26 (21.0) |
Primary tumour (T) | |
T1 | 30 (24.2) |
T2 | 50 (40.3) |
T3 | 21 (16.9) |
T4 | 23 (18.5) |
Nodal status (N) | |
N0 | 24 (19.4) |
N1 | 32 (25.8) |
N2 | 48 (38.7) |
N3 | 20 (16.1) |
Stage | |
I | 7 (5.6) |
II | 31 (25.0) |
III | 46 (37.1) |
IV | 40 (32.2) |
Histological grade | |
Keratinising | 5 (4.0) |
Non-keratinising/differentiated | 54 (43.5) |
Non-keratinising/undifferentiated | 65 (52.4) |
EMP2 expression level | |
Positive (>5% tumour cells) | 63 (50.8) |
Negative (≤5% tumour cells) | 61 (49.2) |